One drug used to prevent HIV transmission during pregnancy shows evidence of developmental effects

(Wolters Kluwer Health) The antiretroviral drug atazanavir -- sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy -- may have small but significant effects on infant development, reports a study in the journal AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.